University of Dundee

Latest News

January 2019

  • ‘Gwenda’ by Benny Nemerofsky Ramsay.
    30 Jan 2019

    A new exhibition that explores perceptions of gender in science will go on display this week at the University of Dundee. ‘Disentangle: Science in a Gendered World’, the latest exhibition at the University’s LifeSpace Gallery, will explore how ideas of gender impact on research through an array of contemporary art, historical objects and scientific case studies.

  • RSB Advanced Accreditation logo
    24 Jan 2019

    All our integrated masters (MSci) programmes in Biological and Biomedical Sciences are now fully accredited by the Royal Society of Biology. Previously they had been granted interim Advanced Accreditation, when our degrees had not yet had any graduates. This award builds on the accreditation of our BSc Honours programmes awarded by the Royal Society of Biology in 2016, and makes Dundee one of only eleven universities in the UK to offer a suite of courses which are both accredited at BSc Honours level and have advanced accreditation at MSci level.

  • 16 Jan 2019

    A number of school prizes were presented at Review of the Year today. Innovator of the Year New for this year, Innovator of the Year, two categories were introduced for best innovation and for early-stage new business ideas. In partnership with the Centre of Entrepreneurship, the winners are guaranteed an automatic place in the appropriate category of the University of Dundee, Venture 2019 Final, plus a chance to participate in the on-campus three month summer Elevator accelerator programme.

  • Exscientia team
    07 Jan 2019

    Exscientia, a world leader in artificial intelligence (“AI”) driven drug discovery and a spinout company of the University of Dundee, has made two announcements today regarding major investments and collaboration.

  • Professor Alessio Ciulli
    07 Jan 2019

    ·        Boehringer Ingelheim to make BET degrader compound MZ 1 available through its opnMe.com portal ·        Support of open access to boost progress in biomedical and drug discovery research